fashion -WSS

fashion

author：comprehensive 2025-10-01 10:37:23 - browse：9

Among the pharmaceutical companies’ many objections to the Biden administration’s drug pricing program is a set of provisions the industry says will warp how cancer drugs are developed. On Wednesday, AstraZeneca CEO Pascal Soriot proposed a new solution.

“What we were asking — and are asking now — is a very simple fix,” said Soriot at the STAT Future Summit, saying that “the impact on health care costs would be very marginal.”

The problem, executives say, is that companies developing cancer drugs today generally start small and then go big. They seek approval first in a small setting, such as patients who have exhausted all other therapies, where it’s easiest in terms of trial size and length to show a benefit. Then they go into larger settings, such as newly diagnosed patients, where studies take longer but the revenue potential is much higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： The pain doctors face in trying to build their families

entertainment

WSS

Biotech incubator Curie.Bio graduates its first startup

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

Removing probiotics from the NICU could threaten preemies' health

The pain doctors face in trying to build their families

White House calls on federal agencies to crack down on AI abuses

New details revealed about Purdue's marketing of OxyContin

explore

fashion

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Abortion clinic in Cancun will cater to Americans

Medical records are filled with copy

Extreme heat events are a public health emergency

How one medical school became remarkably diverse

Patient advocates sound warning on FDA proposal on salt intake

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Cancer drug shortages' outsize impact on ovarian cancer patients

At least 13 dead in Texas as scorching temps continue

Study: New antibiotic targets gonorrhea as well as last existing drug

focus

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Ambulance rides for just $100? Advisers want major billing fixes

10 million people disenrolled from Medicaid over past six months

Medicare will require more price transparency from hospitals

ActiGraph execs on goal of drug approvals with digital endpoints

knowledge

entertainment

entertainment

explore